Hans Grönlund Selected Research

Hans Grönlund Research Topics

Disease

20	Hypersensitivity (Allergy) 06/2022 - 12/2002
12	Asthma (Bronchial Asthma) 10/2022 - 06/2008
7	Multiple Sclerosis 04/2022 - 02/2016
3	Inflammation (Inflammations) 10/2022 - 01/2008
3	Autoimmune Diseases (Autoimmune Disease) 09/2021 - 01/2018
2	Neoplasms (Cancer) 01/2022 - 01/2019
2	Sarcoidosis (Schaumann Disease) 01/2016 - 03/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 03/2010 - 04/2009
1	Respiratory Hypersensitivity 10/2022
1	Rhinitis 06/2022
1	Conjunctivitis 06/2022
1	Dermatitis 06/2022
1	Psychotic Disorders (Schizoaffective Disorder) 11/2020
1	Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis) 11/2020
1	Tetanus 01/2019
1	Diphtheria 01/2019
1	Infections 01/2016
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2016
1	Fibrosis (Cirrhosis) 03/2015
1	Myositis (Idiopathic Inflammatory Myopathies) 03/2015
1	Human Influenza (Influenza) 10/2014
1	Milk Hypersensitivity (Milk Allergy) 12/2012
1	Hepatitis B 06/2011
1	Hypertension (High Blood Pressure) 06/2009
1	Myocardial Infarction 06/2009
1	Atherosclerosis 04/2009
1	Ischemic Stroke 04/2009
1	Granuloma 10/2004
1	Necrosis 10/2004

Drug/Important Bio-Agent (IBA)

19	AllergensIBA 10/2022 - 10/2003
13	Immunoglobulin E (IgE)IBA 06/2022 - 12/2002
8	Proteins (Proteins, Gene)FDA Link 10/2022 - 06/2011
8	AntibodiesIBA 12/2019 - 04/2009
6	Immunoglobulin G (IgG)IBA 01/2020 - 02/2007
5	VaccinesIBA 10/2014 - 12/2010
4	Biomarkers (Surrogate Marker)IBA 06/2022 - 07/2009
3	LipocalinsIBA 05/2022 - 08/2013
3	Peptides (Polypeptides)IBA 01/2022 - 07/2009
3	AntigensIBA 01/2019 - 10/2014
3	EpitopesIBA 04/2011 - 03/2007
3	CarbohydratesIBA 04/2011 - 10/2004
3	Immunoglobulin M (IgM)IBA 03/2010 - 04/2009
3	Phosphorylcholine (Phosphocholine)IBA 03/2010 - 04/2009
2	AutoantigensIBA 04/2022 - 03/2015
2	AutoantibodiesIBA 11/2020 - 01/2016
2	Budesonide (Pulmicort)FDA LinkGeneric 08/2014 - 03/2014
2	Methacholine Chloride (Methacholine)FDA Link 03/2014 - 06/2012
2	EndotoxinsIBA 01/2008 - 02/2007
1	F 4 (F-4)IBA 05/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	Immunomodulating AgentsIBA 09/2021
1	Myelin-Oligodendrocyte GlycoproteinIBA 01/2019
1	Blood Proteins (Serum Proteins)IBA 01/2019
1	HLA-DR15 antigenIBA 01/2018
1	AnoctaminsIBA 02/2016
1	Adenosine Diphosphate (ADP)IBA 03/2015
1	Ribosomal Proteins (Ribosomal Protein)IBA 03/2015
1	GTPase-Activating Proteins (GTPase-Activating Protein)IBA 03/2015
1	poly(ethylmethacrylate)IBA 10/2014
1	Pharmaceutical PreparationsIBA 08/2014
1	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2014
1	SteroidsIBA 03/2014
1	Galactose (Galactopyranose)FDA LinkGeneric 04/2011
1	oxidized low density lipoproteinIBA 03/2010
1	HLA-DR1 Antigen (HLA DR1 Antigen)IBA 07/2009
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 07/2009
1	C-Reactive ProteinIBA 06/2009
1	CholesterolIBA 06/2009
1	LipopolysaccharidesIBA 01/2008
1	Glycoproteins (Glycoprotein)IBA 07/2007
1	P-2 (P 2)IBA 02/2007
1	aluminum sulfate (alum)IBA 10/2004
1	CytokinesIBA 10/2004
1	Interleukin-8 (Interleukin 8)IBA 10/2004
1	Indicators and Reagents (Reagents)IBA 10/2003

Therapy/Procedure

9	Immunotherapy 06/2022 - 12/2002
6	Therapeutics 09/2021 - 06/2008
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022 - 01/2019
1	Sublingual Administration 10/2022
1	Microspheres (Microsphere) 01/2022
1	Injections 05/2012